{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:51:08Z","timestamp":1791805868833,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:00:00Z","timestamp":1309996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00417-011-1730-9","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T19:49:16Z","timestamp":1309981756000},"page":"1649-1660","source":"Crossref","is-referenced-by-count":39,"title":["The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)"],"prefix":"10.1007","volume":"249","author":[{"given":"Khaled","family":"Nassar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"L\u00fcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"L\u00fcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effat","family":"Abd El-Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,7]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/01.ico.0000263121.45898.d2","volume":"21","author":"H Tanihara","year":"2002","unstructured":"Tanihara H, Inatani M, Koga T, Yano T, Kimura A (2002) Proteoglycans in the eye. Cornea 21:S62\u2013S69","journal-title":"Cornea"},{"key":"1730_CR2","first-page":"28","volume":"2","author":"M Hagedorn","year":"1993","unstructured":"Hagedorn M, Esser P, Wiedemann P, Heimann K (1993) Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ger J Ophthalmol 2:28\u201331","journal-title":"Ger J Ophthalmol"},{"key":"1730_CR3","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1074\/jbc.274.27.18843","volume":"27","author":"R Iozzo","year":"1999","unstructured":"Iozzo R (1999) The biology of the small leucine-rich proteoglycan. J Biol Chem 27:18843\u201318846","journal-title":"J Biol Chem"},{"key":"1730_CR4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj2230587","volume":"223","author":"KG Vogel","year":"1984","unstructured":"Vogel KG, Paulsson M, Heinegard D (1984) Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223:587\u2013597","journal-title":"Biochem J"},{"key":"1730_CR5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/1047-8477(91)90065-5","volume":"106","author":"R Fleischmajer","year":"1991","unstructured":"Fleischmajer R, Fisher LW, MacDonald ED, Jacobs L Jr, Perlish JS, Termine JD (1991) Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol 106:82\u201390","journal-title":"J Struct Biol"},{"key":"1730_CR6","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1016\/S0021-9258(18)42759-7","volume":"267","author":"DJ Bidanset","year":"1992","unstructured":"Bidanset DJ, Guidry C, Rosenberg LC, Choi HU, Timpl R, Hook M (1992) Binding of the proteoglycan decorin to collagen type VI. J Biol Chem 267:5250\u20135256","journal-title":"J Biol Chem"},{"key":"1730_CR7","first-page":"47","volume":"59","author":"M Winnemoller","year":"1992","unstructured":"Winnemoller M, Schon P, Vischer P, Kresse H (1992) Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol 59:47\u201355","journal-title":"Eur J Cell Biol"},{"key":"1730_CR8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1083\/jcb.105.3.1443","volume":"105","author":"K Lewandowska","year":"1987","unstructured":"Lewandowska K, Choi HU, Rosenberg LC, Zardi L, Culp LA (1987) Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain. J Cell Biol 105:1443\u20131454","journal-title":"J Cell Biol"},{"key":"1730_CR9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1083\/jcb.104.6.1683","volume":"104","author":"G Schmidt","year":"1987","unstructured":"Schmidt G, Robenek H, Harrach B, Gl\u00f6ssl J, Nolte V, H\u00f6rmann H, Richter H, Kresse H (1987) Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J Cell Biol 104:1683\u20131691","journal-title":"J Cell Biol"},{"key":"1730_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0174-173X(87)80002-X","volume":"7","author":"KG Vogel","year":"1987","unstructured":"Vogel KG, Trotter JA (1987) The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Coll Relat Res 7:105\u2013114","journal-title":"Coll Relat Res"},{"key":"1730_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","volume":"346","author":"Y Yamaguchi","year":"1990","unstructured":"Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor- by the proteoglycan decorin. Nature 346:281\u2013284","journal-title":"Nature"},{"key":"1730_CR12","doi-asserted-by":"crossref","first-page":"32634","DOI":"10.1016\/S0021-9258(18)31681-8","volume":"269","author":"Y Takeuchi","year":"1994","unstructured":"Takeuchi Y, Kodama Y, Matsumoto T (1994) Bone matrix decorin binds transforming growth factor- and enhances its bioactivity. J Biol Chem 269:32634\u201332638","journal-title":"J Biol Chem"},{"key":"1730_CR13","unstructured":"Vial C, Gutierrez J, Santander C, Cabrera D, Brandan E (2011) Decorin interacts with CTGF\/CCN2 through LRR12 inhibiting its biological activity. J Biol Chem 2011 Mar 23. [Epub ahead of print]"},{"key":"1730_CR14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)63447-5","volume":"163","author":"N Nili","year":"2003","unstructured":"Nili N, Cheema AN, Giordano FJ, Barolet AW, Babaei S, Hickey R, Eskandarian MR, Smeets M, Butany J, Pasterkamp G, Strauss BH (2003) Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function. Am J Pathol 163:869\u2013878","journal-title":"Am J Pathol"},{"key":"1730_CR15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1172\/JCI846","volume":"101","author":"DK Moscatello","year":"1998","unstructured":"Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 101:406\u2013412","journal-title":"J Clin Invest"},{"key":"1730_CR16","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1074\/jbc.274.8.4489","volume":"274","author":"RV Iozzo","year":"1999","unstructured":"Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274:4489\u20134493","journal-title":"J Biol Chem"},{"key":"1730_CR17","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1074\/jbc.273.6.3121","volume":"273","author":"S Patel","year":"1998","unstructured":"Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP (1998) Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 273:3121\u20133124","journal-title":"J Biol Chem"},{"key":"1730_CR18","first-page":"325","volume":"71","author":"H Hausser","year":"1996","unstructured":"Hausser H, Wedekind P, Sperber T, Peters R, Hasilik A, Kresse H (1996) Isolation and cellular localization of the decorin endocytosis receptor. Eur J Cell Biol 71:325\u2013331","journal-title":"Eur J Cell Biol"},{"key":"1730_CR19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archopht.1979.01020010230008","volume":"97","author":"WF Rachal","year":"1979","unstructured":"Rachal WF, Burton TC (1979) Changing concepts of failure after retinal detachment surgery. Arch Ophthalmol 97:480\u2013483","journal-title":"Arch Ophthalmol"},{"key":"1730_CR20","first-page":"900","volume":"35","author":"DJ Kauffmann","year":"1994","unstructured":"Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME (1994) Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sic 35:900\u2013906","journal-title":"Invest Ophthalmol Vis Sic"},{"key":"1730_CR21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/eye.1991.126","volume":"5","author":"GA Limb","year":"1991","unstructured":"Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC (1991) Cytokines in proliferative vitreoretinopathy. Eye 5:686\u2013693","journal-title":"Eye"},{"key":"1730_CR22","first-page":"2062","volume":"40","author":"RP Casaroli-Marano","year":"1999","unstructured":"Casaroli-Marano RP, Pagan R, Vilar\u00f3 S (1999) Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40:2062\u20132072","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1730_CR23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776\u20131784","journal-title":"J Clin Invest"},{"key":"1730_CR24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI12749","volume":"107","author":"P Bornstein","year":"2001","unstructured":"Bornstein P (2001) Thrombospondins as matricellular modulators of cell function. J Clin Invest 107:929\u2013934","journal-title":"J Clin Invest"},{"key":"1730_CR25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1242\/jcs.108.3.985","volume":"108","author":"M Shah","year":"1995","unstructured":"Shah M, Foreman DM, Ferguson MW (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sic 108:985\u20131002","journal-title":"J Cell Sic"},{"key":"1730_CR26","first-page":"2225","volume":"40","author":"MF Cordeiro","year":"1999","unstructured":"Cordeiro MF, Gay JA, Khaw PT (1999) Human anti-transforming growth factor-2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 40:2225\u20132234","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1730_CR27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0161-6420(01)00997-6","volume":"190","author":"D Siriwardena","year":"2002","unstructured":"Siriwardena D, Khaw PT, King AJ (2002) Human antitransforming growth factor beta (2) monoclonal antibody, a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. Ophthalmology 190:427\u2013431","journal-title":"Ophthalmology"},{"key":"1730_CR28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1167\/iovs.04-0902","volume":"46","author":"S Grisanti","year":"2005","unstructured":"Grisanti S, Szurman P, Warga M, Kaczmarek R, Ziemssen F, Tatar O, Bartz-Schmidt KU (2005) Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study. Invest Ophthalmol Vis Sci 46:191\u2013196","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1730_CR29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bjo.63.5.306","volume":"63","author":"PE Cleary","year":"1979","unstructured":"Cleary PE, Ryan SJ (1979) Experimental posterior penetrating eye injury in the rabbit I. Method of production and natural history. Br J Ophthalmol 63:306\u2013311","journal-title":"Br J Ophthalmol"},{"key":"1730_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02144122","volume":"224","author":"HT Hsu","year":"1986","unstructured":"Hsu HT, Ryan SJ (1986) Natural history of penetrating ocular injury with retinal laceration in the monkey. Graefes Arch Clin Exp Ophthalmol 224:1\u20136","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1730_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nprot.2007.4","volume":"2","author":"RN Agrawal","year":"2007","unstructured":"Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR (2007) In vivo models of proliferative vitreoretinopathy. Nat Protoc 2:67\u201377","journal-title":"Nat Protoc"},{"key":"1730_CR32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0014-4835(89)80030-2","volume":"49","author":"O Vergara","year":"1989","unstructured":"Vergara O, Ogden T, Ryan SJ (1989) Posterior penetrating injury to the rabbit eye: effect of blood and ferrous ions. Exp Eye Res 49:1115\u20131126","journal-title":"Exp Eye Res"},{"key":"1730_CR33","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0161-6420(97)30167-5","volume":"104","author":"JA Cardillo","year":"1997","unstructured":"Cardillo JA, Stout JT, LaBree L, Azen SP, Omphroy L, Cui JZ, Kimura H, Hinton DR, Ryan SJ (1997) Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104:1166\u20131173","journal-title":"Ophthalmology"},{"key":"1730_CR34","doi-asserted-by":"crossref","DOI":"10.1002\/9780470755266","volume-title":"Ophthalmic pathology: an illustrated guide for clinicians","author":"W Sehu","year":"2005","unstructured":"Sehu W, Lee W (2005) Ophthalmic pathology: an illustrated guide for clinicians. Blackwell Publishing Ltd, Massachusetts"},{"key":"1730_CR35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2003.039917","volume":"88","author":"JA Cardillo","year":"2004","unstructured":"Cardillo JA, Farah ME, Mitre J, Morales PH, Costa RA, Melo LA, Kuppermann B, Jorge R, Ashton P (2004) An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy. Br J Ophthalmol 88:1201\u20131205","journal-title":"Br J Ophthalmol"},{"key":"1730_CR36","unstructured":"Roduit N (2010) JMicroVision: Image analysis toolbox for measuring and quantifying components of high-definition images. Version 1.2.2. http:\/\/www.jmicrovision.com . Access on 8 January 2010"},{"key":"1730_CR37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bjo.79.10.953","volume":"79","author":"DG Charteris","year":"1995","unstructured":"Charteris DG (1995) Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 79:953\u2013960","journal-title":"Br J Ophthalmol"},{"key":"1730_CR38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)75004-4","volume":"100","author":"SJ Ryan","year":"1985","unstructured":"Ryan SJ (1985) The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol 100:188\u2013193","journal-title":"Am J Ophthalmol"},{"key":"1730_CR39","doi-asserted-by":"crossref","first-page":"L1327","DOI":"10.1152\/ajplung.2001.280.6.L1327","volume":"280","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Sime PJ, Gauldie J (2001) Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280:L1327\u2013L1334","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1730_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004410051283","volume":"296","author":"M St\u00e4nder","year":"1999","unstructured":"St\u00e4nder M, Naumann U, Wick W, Weller M (1999) Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296:221\u2013227","journal-title":"Cell Tissue Res"},{"key":"1730_CR41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1097-4644(19971001)67:1<75::AID-JCB8>3.0.CO;2-T","volume":"67","author":"B Merle","year":"1997","unstructured":"Merle B, Malaval L, Lawler J, Delmas P, Clezadin P (1997) Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1. J Cell Biochem 67:75\u201383","journal-title":"J Cell Biochem"},{"key":"1730_CR42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<538::AID-JCB17>3.0.CO;2-Y","volume":"75","author":"B Merle","year":"1999","unstructured":"Merle B, Durussel L, Delmas PD, Clezardin P (1999) Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem 75:538\u2013546","journal-title":"J Cell Biochem"},{"key":"1730_CR43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/336244a0","volume":"336","author":"Y Yamaguchi","year":"1988","unstructured":"Yamaguchi Y, Ruoslahti E (1988) Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation. Nature 336:244\u2013246","journal-title":"Nature"},{"key":"1730_CR44","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.271.31.18961","volume":"271","author":"A Luca De","year":"1996","unstructured":"De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV (1996) Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 271:18961\u201318965","journal-title":"J Biol Chem"},{"key":"1730_CR45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm0496-418","volume":"2","author":"Y Isaka","year":"1996","unstructured":"Isaka Y, Brees D, Ikegaya K, Kaneda Y, Imai E, Noble N (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2:418\u2013423","journal-title":"Nat Med"},{"key":"1730_CR46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0006-2952(97)00343-2","volume":"54","author":"S Giri","year":"1997","unstructured":"Giri S, Hyde D, Braun R, Gaarde W (1997) Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 54:1205\u20131217","journal-title":"Biochem Pharmacol"},{"key":"1730_CR47","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/exnr.1999.7180","volume":"159","author":"A Logan","year":"1999","unstructured":"Logan A, Baird A, Berry M (1999) Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 159:504\u2013510","journal-title":"Exp Neurol"},{"key":"1730_CR48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/03635465010290040201","volume":"29","author":"K Fukushima","year":"2001","unstructured":"Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J (2001) The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29:394\u2013402","journal-title":"Am J Sports Med"},{"key":"1730_CR49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2010.05.013","volume":"91","author":"RR Mohan","year":"2010","unstructured":"Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S (2010) Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Re 91:238\u2013245","journal-title":"Exp Eye Re"},{"key":"1730_CR50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bjo.64.11.801","volume":"64","author":"PE Cleary","year":"1979","unstructured":"Cleary PE, Larus G, Ryan SJ (1979) Experimental posterior penetrating eye injury in the rhesus monkey: vitreous-lens admixture. Br J Ophthalmol 64:801\u2013808","journal-title":"Br J Ophthalmol"},{"key":"1730_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archopht.1981.03930010289014","volume":"99","author":"PE Cleary","year":"1981","unstructured":"Cleary PE, Ryan SJ (1981) Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey. Arch Ophthalmol 99:287\u2013292","journal-title":"Arch Ophthalmol"},{"key":"1730_CR52","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bjo.63.5.312","volume":"63","author":"PE Cleary","year":"1979","unstructured":"Cleary PE, Ryan SJ (1979) Experimental posterior penetrating eye injury in the rabbit II. Histology of wound, vitreous, and retina. Br J Ophthalmol 63:312\u2013321","journal-title":"Br J Ophthalmol"},{"key":"1730_CR53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00006982-198600610-00007","volume":"6","author":"HT Hsu","year":"1986","unstructured":"Hsu HT, Ryan SJ (1986) Experimental retinal detachment in the rabbit. Penetrating ocular injury with retinal laceration. Retina 6:66\u201369","journal-title":"Retina"},{"key":"1730_CR54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00200486","volume":"233","author":"CE Margo","year":"1995","unstructured":"Margo CE, Lee A (1995) Fixation of whole eyes: the role of fixative osmolarity in the production of tissue artifact. Graefe's Arch Clin Exp Ophthalmol 233:366\u2013370","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"1730_CR55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9394(82)90239-2","volume":"94","author":"MS Blumenkranz","year":"1982","unstructured":"Blumenkranz MS, Ophir A, Clafiin AJ, Kajek A (1982) Fluorouracil for the treatment of massive preretinal proliferation. Am J Ophthalmol 94:458\u2013467","journal-title":"Am J Ophthalmol"},{"key":"1730_CR56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9394(14)77369-6","volume":"93","author":"DM Fastenberg","year":"1982","unstructured":"Fastenberg DM, Diddie KR, Sorgente N, Ryan SJ (1982) A comparison of different cellular innocula in an experimental model of massive periretinal proliferation. Am J Ophthalmol 93:559\u2013564","journal-title":"Am J Ophthalmol"},{"key":"1730_CR57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0002-9394(14)77370-2","volume":"93","author":"DM Fastenberg","year":"1982","unstructured":"Fastenberg DM, Diddie KR, Dorey K, Ryan SJ (1982) The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol 93:565\u2013572","journal-title":"Am J Ophthalmol"},{"key":"1730_CR58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02150154","volume":"225","author":"T Hida","year":"1987","unstructured":"Hida T, Chandler DB, Sheta SM (1987) Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye. Graefes Arch Clin Exp Ophthalmol 225:303\u2013307","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1730_CR59","first-page":"224","volume-title":"Ocular trauma principles and practice","author":"KG Au Eong","year":"2002","unstructured":"Au Eong KG, Kent D, Pieramici DJ (2002) Section III Mechanical globe injuries, chapter 23 vitreous and retina. In: Kuhn F, Pieramici DJ (eds) Ocular trauma principles and practice. Thieme Medical Publishers, New York, p 224"},{"key":"1730_CR60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(99)00104-6","volume":"44","author":"RA Mittra","year":"1999","unstructured":"Mittra RA, Mieler WF (1999) Controversies in the management of open-globe injuries involving the posterior segment. Surv Ophthalmol 44:215\u2013225","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"1730_CR61","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/00006982-199010001-00013","volume":"10","author":"SC Spalding","year":"1990","unstructured":"Spalding SC, Sternberg P Jr (1990) Controversies in the management of posterior segment ocular trauma. Retina 10(Suppl 1):S76\u2013S82","journal-title":"Retina"},{"key":"1730_CR62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000101928","volume":"221","author":"NK Wang","year":"2007","unstructured":"Wang NK, Chen YP, Yeung L, Chen KJ, Chao AN, Kuo YH, Lee JS, Lai CC (2007) Traumatic pediatric retinal detachment following open globe injury. Ophthalmologica 221:255\u2013263","journal-title":"Ophthalmologica"},{"key":"1730_CR63","first-page":"11","volume-title":"Intraocular drug delivery","author":"P Ashton","year":"2006","unstructured":"Ashton P (2006) Retinal Drug Delivery. In: Jaffe JG, Ashton P, Pearson PA (eds) Intraocular drug delivery. Taylor and Francis Group, New York, pp 11\u201312"},{"key":"1730_CR64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00006982-199414050-00005","volume":"14","author":"P Girard","year":"1994","unstructured":"Girard P, Mimoun G, Karpouzas I, Montefiore G (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14:417\u2013424","journal-title":"Retina"},{"key":"1730_CR65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00055735-199512000-00012","volume":"6","author":"H Nagasaki","year":"1995","unstructured":"Nagasaki H, Shinagawa K (1995) Risk factors for proliferative vitreoretinopathy. Curr Opin Ophthalmol 6:70\u201375","journal-title":"Curr Opin Ophthalmol"},{"key":"1730_CR66","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/156652411794859241","volume":"11","author":"RR Mohan","year":"2011","unstructured":"Mohan RR, Tovey JC, Gupta R, Sharma A, Tandon A (2011) Decorin biology, expression, function and therapy in the cornea. Curr Mol Med 11:110\u2013128","journal-title":"Curr Mol Med"},{"key":"1730_CR67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.burns.2008.07.012","volume":"5","author":"J Meenakshi","year":"2009","unstructured":"Meenakshi J, Vidyameenakshi S, Ananthram D, Ramakrishnan KM, Jayaraman V, Babu M (2009) Low decorin expression along with inherent activation of ERK1, 2 in ear lobe keloids. Burns 5:519\u2013526","journal-title":"Burns"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1730-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1730-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T18:02:28Z","timestamp":1638036148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1730-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1730-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}